Progressive cavitating leukoencephalopathy : four cases and literatures review

Objective: To analyze the clinical and genetic features of progressive cavitating leukoencephalopathy (PCL). Method: The data of clinical and genetic features of 4 PCL patients diagnosed by Beijing Children's Hospital between January 2015 and January 2016 were analyzed. The cases with complete...

Description complète

Détails bibliographiques
Publié dans:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 55(2017), 4 vom: 02. Apr., Seite 283-287
Auteur principal: Ren, C H (Auteur)
Autres auteurs: Fang, F, Cheng, H, Ding, C H, Chen, C H, Zhang, Y J, Shen, D M
Format: Article en ligne
Langue:Chinese
Publié: 2017
Accès à la collection:Zhonghua er ke za zhi = Chinese journal of pediatrics
Sujets:Case Reports Journal Article Review Gene, NDUFS1 Gene, NDUFV1 Leukoencephalopathy, progressive multifocal NDUFS1 protein, human NDUFV1 protein, human NADH Dehydrogenase EC 1.6.99.3 plus... Electron Transport Complex I EC 7.1.1.2
LEADER 01000caa a22002652c 4500
001 NLM27128093X
003 DE-627
005 20250221133355.0
007 cr uuu---uuuuu
008 231224s2017 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.issn.0578-1310.2017.04.010  |2 doi 
028 5 2 |a pubmed25n0904.xml 
035 |a (DE-627)NLM27128093X 
035 |a (NLM)28441825 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Ren, C H  |e verfasserin  |4 aut 
245 1 0 |a Progressive cavitating leukoencephalopathy  |b four cases and literatures review 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 07.08.2017 
500 |a Date Revised 09.12.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To analyze the clinical and genetic features of progressive cavitating leukoencephalopathy (PCL). Method: The data of clinical and genetic features of 4 PCL patients diagnosed by Beijing Children's Hospital between January 2015 and January 2016 were analyzed. The cases with complete clinical data retrieved on literature search at China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform and PubMed (up to August 2016) by using search terms of"NDUFV1" ,"NDUFS1" , or"leukoencephalopathy" , were summarized. Result: There were three females and one male, two of which were compatriots. The age of onset ranged from 6 months to 15 months. All four children's first symptoms were motor development regression, and the developmental milestones were almost normal before the onset. Of the 4 patients, 3 had cognitive impairment, 1 had seizures, 4 had dystonia and pyramidal impairment, 2 had emaciation, and 1 had nystagmus. The lactate concentrations of 4 patients were normal in blood. One patient had lactaciduria in the urinary organic acid analysis. Cranial magnetic resonance imaging (MRI) of all patients showed leukoencephalopathy, involved in the corpus callosum, and three patients accompanied by cystic lesions. Follow up for 2-13 years showed that the physical and language development were improved. Genetic analysis revealed that mutations in NDUFS1 were found in three patients and NDUFV1 mutation was found in one patient. All six mutations (p.Arg377Cys and p. Arg377His in NDUFV1; p. Arg482Glyfs(*)5, p.Thr368Pro, p.Tyr454X and p. Asp565Gly in NDUFS1) are novel. Five English case reports including 10 PCL patients were collected. Together with this group of 4 cases, a total of 14 cases were involved. All 14 children patients had motor development regression, 11 cases had cognitive impairment and dystonia, 6 cases had pyramidal impairment, 5 cases had irritability, 4 cases had epilepsy and nystagmus, 3 cases had strabismus and swallowing difficulty. Cranial MRI showed patchy leukoencephalopathy with cavities, involved in the corpus callosum. Follow up for 19 months-15 years that the neurology development were improved slowly in all patients. Conclusion: NDUFS1 and NDUFV1 gene mutation screening should be performed firstly in patients with PCL clinical and imaging feature 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a Gene, NDUFS1 
650 4 |a Gene, NDUFV1 
650 4 |a Leukoencephalopathy, progressive multifocal 
650 7 |a NDUFS1 protein, human  |2 NLM 
650 7 |a NDUFV1 protein, human  |2 NLM 
650 7 |a NADH Dehydrogenase  |2 NLM 
650 7 |a EC 1.6.99.3  |2 NLM 
650 7 |a Electron Transport Complex I  |2 NLM 
650 7 |a EC 7.1.1.2  |2 NLM 
700 1 |a Fang, F  |e verfasserin  |4 aut 
700 1 |a Cheng, H  |e verfasserin  |4 aut 
700 1 |a Ding, C H  |e verfasserin  |4 aut 
700 1 |a Chen, C H  |e verfasserin  |4 aut 
700 1 |a Zhang, Y J  |e verfasserin  |4 aut 
700 1 |a Shen, D M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 55(2017), 4 vom: 02. Apr., Seite 283-287  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnas 
773 1 8 |g volume:55  |g year:2017  |g number:4  |g day:02  |g month:04  |g pages:283-287 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2017.04.010  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
912 |a GBV_ILN_1121 
951 |a AR 
952 |d 55  |j 2017  |e 4  |b 02  |c 04  |h 283-287